Douglass Winthrop Advisors, LLC Merck & Co., Inc. Transaction History

Douglass Winthrop Advisors, LLC

$5.09 Billion
Q3 2024

A detailed history of Douglass Winthrop Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 328,743 shares of MRK stock, worth $32.2 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

328,743

Previous 336,818 2.4%

Holding current value

$32.2 Million

Previous $41.7 Million 10.47%

% of portfolio

0.73%

Previous 0.87%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $36.5 Million - $42.4 Million	328,743 New	328,743 $37.3 Million
Q2 2024 Aug 07, 2024	SELL	$123.8 - $132.96 $11.2 Million - $12 Million	-90,149 Reduced 21.11%	336,818 $41.7 Million
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $2.51 Million - $2.92 Million	22,151 Added 5.47%	426,967 $56.3 Million
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $512,120 - $557,310	5,112 Added 1.28%	404,816 $44.1 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $41.1 Million - $45.7 Million	399,704 New	399,704 $41.1 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $285,752 - $311,457	-2,631 Reduced 0.63%	413,377 $47.7 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $42.8 Million - $47.8 Million	416,008 New	416,008 $44.3 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $36.9 Million - $47.4 Million	422,411 New	422,411 $46.9 Million
Q3 2022 Nov 15, 2022	BUY	$84.53 - $94.96 $33.1 Million - $37.2 Million	391,849 New	391,849 $33.7 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $33.3 Million - $37.8 Million	398,929 New	398,929 $36.4 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $36.8 Million - $41.3 Million	-501,063 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $61.3 Million - $76.7 Million	-847,416 Reduced 62.84%	501,063 $38.4 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $482,048 - $530,131	6,725 Added 0.5%	1,348,479 $101 Million
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $6.74 Million - $7.45 Million	-95,845 Reduced 6.67%	1,341,754 $104 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $99 Million - $117 Million	1,437,599 New	1,437,599 $111 Million
Q4 2020 Jan 27, 2021	SELL	$71.77 - $79.65 $56.2 Million - $62.4 Million	-783,238 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $57.3 Million - $65 Million	783,238 New	783,238 $65 Million
Q2 2020 Jul 17, 2020	BUY	$70.42 - $80.13 $2.8 Million - $3.18 Million	39,713 Added 27.62%	183,472 $14.2 Million
Q1 2020 Apr 23, 2020	SELL	$63.36 - $87.82 $198,950 - $275,754	-3,140 Reduced 2.14%	143,759 $11.1 Million
Q4 2019 Jan 10, 2020	SELL	$77.58 - $87.54 $417,457 - $471,052	-5,381 Reduced 3.53%	146,899 $13.4 Million
Q3 2019 Oct 08, 2019	SELL	$76.08 - $82.93 $525,104 - $572,382	-6,902 Reduced 4.34%	152,280 $12.8 Million
Q2 2019 Jul 10, 2019	SELL	$69.84 - $81.59 $455,706 - $532,374	-6,525 Reduced 3.94%	159,182 $13.3 Million
Q1 2019 Apr 09, 2019	SELL	$69.58 - $79.36 $749,376 - $854,707	-10,770 Reduced 6.1%	165,707 $13.8 Million
Q4 2018 Jan 16, 2019	BUY	$65.24 - $75.71 $673,015 - $781,024	10,316 Added 6.21%	176,477 $13.5 Million
Q3 2018 Oct 12, 2018	SELL	$57.69 - $67.84 $6.7 Million - $7.88 Million	-116,096 Reduced 41.13%	166,161 $11.8 Million
Q2 2018 Jul 24, 2018	SELL	$50.83 - $59.72 $758,891 - $891,619	-14,930 Reduced 5.02%	282,257 $17.1 Million
Q1 2018 May 08, 2018	BUY	$50.96 - $59.23 $68,031 - $79,072	1,335 Added 0.45%	297,187 $16.2 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $15.5 Million - $18.5 Million	-300,328 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $17.6 Million - $19 Million	300,328	300,328 $0

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.

Account

Douglass Winthrop Advisors, LLC Merck & Co., Inc. Transaction History